DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
TD-4208 is an investigational drug.
There have been 13 clinical trials for TD-4208. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2015.
The most common disease conditions in clinical trials are Pulmonary Disease, Chronic Obstructive, Lung Diseases, Obstructive, and Lung Diseases. The leading clinical trial sponsors are Theravance Biopharma R & D, Inc., Theravance Biopharma, and Mylan Inc.
There are thirty-three US patents protecting this investigational drug and one hundred and twenty-two international patents.
Recent Clinical Trials for TD-4208
|A 42-day Parallel Group Safety Study of Revefenacin and Formoterol, Administered in Sequence and as a Combination, in Subjects With COPD||Mylan Inc.||Phase 3|
|A 42-day Parallel Group Safety Study of Revefenacin and Formoterol, Administered in Sequence and as a Combination, in Subjects With COPD||Theravance Biopharma||Phase 3|
|Revefenacin Peak Inspiratory Flow Rate (PIFR) Study in COPD||Theravance Biopharma R & D, Inc.||Phase 3|
Top disease conditions for TD-4208
Top clinical trial sponsors for TD-4208
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|TD-4208||Start Trial||Crystalline freebase forms of a biphenyl compound||THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA)||Start Trial|
|TD-4208||Start Trial||Biphenyl compounds useful as muscarinic receptor antagonists||THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA)||Start Trial|
|TD-4208||Start Trial||Biphenyl compounds useful as muscarinic receptor antagonists||Theravance, Inc. (South San Francisco, CA)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|